Showing results (231-240 of 285) with videos related to

Sort By:
Pageof 29
Journal of Hepatology|September 29, 2011
IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis CTarik Asselah, Simon De Muynck, Philippe Broët, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2014
Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR studyEdward J Gane, Paul J Pockros, Stefan Zeuzem, et al.
Plos One|July 18, 2018
No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis BLai Wei, Heiner Wedemeyer, Yun-Fan Liaw, et al.
Digestive Diseases and Sciences|January 29, 2016
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in FrancePatrick Marcellin, Fabien Zoulim, Christophe Hézode, et al.
Journal of Hepatology|January 8, 2016
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)Henry L Y Chan, Sang Hoon Ahn, Ting-Tsung Chang, et al.
Gastroenterology|May 16, 2006
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient dataGioacchino Leandro, Alessandra Mangia, Jason Hui, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 4, 2014
Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)Scott Fung, Stuart C Gordon, Zahary Krastev, et al.
Journal of Hepatology|January 22, 2014
Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null respondersAnna S Lok, David F Gardiner, Christophe Hézode, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2021
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infectionNicholas van Buuren, Ricardo Ramirez, Scott Turner, et al.
Gut|August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis BJulianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.
Pageof 29